Trevo 3 Mm and/or AXS Catalyst 5 for the Treatment of Medium Distal Vessel Occlusion Stroke-results from the ASSIST Registry.
Nikolaos NtouliasAlex BrehmSalvador MiralbésBharath NaravetlaAlejandro SpiottaChristian LoehrMario Martínez-GaldámezRyan McTaggartLuc DefreynePedro VegaOsama O ZaidatLori Lyn PriceDavid S LiebeskindMarkus MöhlenbruchRishi GuptaMarios-Nikos Psychogiosnull nullPublished in: Clinical neuroradiology (2024)
The data suggests that the Trevo 3 mm SR and/or the AXS Catalyst 5 may be an option to treat medium distal vessel occlusion, but more data is needed to demonstrate safety and efficacy in this patient cohort. Further improvements are needed regarding materials and techniques to improve reperfusion results in this patient cohort in the future.
Keyphrases
- case report
- electronic health record
- room temperature
- ionic liquid
- minimally invasive
- highly efficient
- big data
- reduced graphene oxide
- atrial fibrillation
- cerebral ischemia
- carbon dioxide
- heart failure
- current status
- data analysis
- acute ischemic stroke
- visible light
- machine learning
- gold nanoparticles
- combination therapy
- acute coronary syndrome
- brain injury
- artificial intelligence